Overexpressed N-cadherin, a marker of ongoing EMT, achieves EMT, stemness promoting function and metastatic ability by activating the ErbB signaling in PCa cells, further supporting the hypothesis that N-cadherin could be a promising target in PCa therapy [138]. This evidence concerns the gene CDH2 and posterior cortical atrophy.